Related Experiment Videos
The Otologics MET ossicular stimulator.
1Otologics, LLC, Boulder, Colorado 80301, USA. kasicj@otologics.com
Otolaryngologic Clinics of North America
|May 31, 2001
Summary
New middle ear implants (MEI) offer a novel therapy for sensorineural hearing loss. Clinical trials compare the Otologics middle ear transducer (MET) Ossicular Stimulator against advanced digital hearing aids to assess its effectiveness.
Area of Science:
- Otolaryngology
- Biomedical Engineering
- Hearing Science
Background:
- Advancements in middle ear implant (MEI) technologies enable direct ossicular stimulation.
- A new medical device industry segment is emerging around MEI therapies.
- MEIs offer a potential therapeutic option for hearing loss.
Purpose of the Study:
- To evaluate the efficacy of the Otologics middle ear transducer (MET) Ossicular Stimulator.
- To compare the MET Ossicular Stimulator to a state-of-the-art digital hearing aid for treating hearing loss.
Main Methods:
- A clinical comparison study was conducted.
- The study involved individuals with moderately severe to severe sensorineural hearing loss.
- Efficacy was determined by comparing the MET Ossicular Stimulator to a digital hearing aid.
Main Results:
- The study compared the performance of the MET Ossicular Stimulator against a leading digital hearing aid.
- Results will establish the benefits of the MEI compared to current alternatives.
Conclusions:
- The MET Ossicular Stimulator represents a new therapeutic approach for specific hearing loss.
- Clinical comparison is essential to validate the benefits of novel MEI technologies.